DVA
DaVita Inc.
145.58
100 x 145.75
100 x 146.40
bid
ask
-
4.76
3.17%
100 @ 04:00 PM
145.65 +0.07 (0.05%)
Ytd 28.14%
1y -5.65%
144.78
day range
151.19
103.87
52 week range
156.76
Open 150.22 Prev Close 150.34 Low 144.78 High 151.19 Mkt Cap 9.73B
Vol 970.56K Avg Vol 1.10M EPS 9.51 P/E 15.31 Forward P/E 8.91
Beta 0.93 Short Ratio 6.56 Inst. Own 52.87% Dividend N/A Div Yield N/A
Ex Div Date N/A Earning 05-04 50-d Avg 143.04 200-d Avg 131.96 1yr Est 151.71
Earning
Date For Estimate Reported Surprise surprise %
2026-05-11 2026-03 2.41 N/A N/A N/A
2026-02-02 2025-12 3.24 3.4 0.16 4.94%
2025-10-29 2025-09 3.29 2.51 -0.78 -23.71%
2025-08-05 2025-06 2.7 2.95 0.25 9.26%
2025-05-12 2025-03 1.75 2 0.25 14.29%
2025-02-13 2024-12 2.21 2.24 0.03 1.36%
Upgrade / Downgrade
Date Firm Action From To
2026-02-04 UBS Upgrade Buy Buy
2026-02-03 Barclays Upgrade Equal-Weight Equal-Weight
2025-11-03 TD Cowen Upgrade Hold Hold
2025-10-30 Barclays Upgrade Equal-Weight Equal-Weight
2025-10-09 Barclays Upgrade Equal-Weight Equal-Weight
2025-09-10 B of A Securities Upgrade Underperform Underperform
Profile
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Insider Holder
Date Name Relation Quantity Description
2026-03-12 ACKERMAN JOEL Chief Financial Officer 183.91K Stock Award(Grant)
2026-03-12 ARWAY PAMELA M. Director 26.70K Stock Award(Grant)
2025-05-14 BERG CHARLES G Director 27.03K Stock Award(Grant)
2026-01-28 BERKSHIRE HATHAWAY, INC. Beneficial Owner of more than 10% of a Class of Security 0.00 Sale
2026-03-12 HEARTY JAMES O Officer 38.14K Stock Award(Grant)
2026-03-12 MAUGHAN DAVID PAUL Officer 114.47K Stock Award(Grant)
Institution Ownership
Report Date Organization Position Value Percentage
2025-12-30 Berkshire Hathaway, Inc 31.76M 4.62B 47.54%
2025-12-30 Vanguard Group Inc 4.15M 604.79M 6.22%
2025-12-30 Blackrock Inc. 2.93M 426.02M 4.38%
2025-12-30 Invesco Ltd. 1.68M 245.05M 2.52%
2025-12-30 Morgan Stanley 1.48M 215.03M 2.21%
2025-12-30 State Street Corporation 1.44M 209.42M 2.15%
Fund Ownership
Report Date Organization Position Value Percentage
2026-01-30 Invesco Exchange-Traded Fund Trust-Invesco S&P 500 Equal Weight ETF 1.34M 195.44M 2.01%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 1.12M 163.09M 1.68%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard 500 Index Fund 888.25K 129.31M 1.33%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund 800.71K 116.57M 1.20%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund 516.49K 75.19M 0.77%
2026-01-30 iShares Trust-iShares Core S&P 500 ETF 453.72K 66.05M 0.68%
Split
Split Date
2 : 1 2013-09-09
1.5 : 1 2004-06-16
5 : 3 1997-10-21